AbbVie president Michael Severino heads to Flagship as biotech incubator's third CEO-partner in six days
AbbVie president and vice chair Michael Severino is leaving the Chicago-area pharma giant on May 31 to become a CEO-partner at prolific biotech creator Flagship Pioneering in June. He’s the third CEO-partner to be named at the incubator, which is behind the likes of Moderna, in the past six days.
He notified the Humira drugmaker on April 8 of his new career ambitions, according to an AbbVie SEC filing Wednesday morning. He’s departing after three and a half years in the president and vice chair posts. Prior to that, he spent nearly five years as CSO.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.